NorthWest Biotherapeutics Inc (NWBO)

[Steady_T]

You make several assumptions to support your assertions. The most obvious is there is no deal offered because there is no deal.
Has it occurred to you that maybe the company is willing to wait till after approval when it will have much more leverage in making a deal?

Then there was a recent placement that brought about $3 mil into the company. Why do you assume that other such deals can not be made as needed?
After all, the company has survived a very long time under exceptionally difficult circumstances, why would a few more months suddenly be a big issue? Management knows how to keep the company alive and moving forward.

Once approval is granted the company can immediately start getting revenues by license agreements. That would solve the reimbursement issue that you raise, assuming of course that it is a real issue.

The amount of dilution on a percentage basis is minor given the OS is 1.2billion shares. Compared to the value of making a deal post approval that amount of dilution is trivial.